| 000 | 01150 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516152327.0 | ||
| 264 | 0 | _c20130723 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1097-6744 | ||
| 024 | 7 |
_a10.1016/j.ahj.2013.03.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJung, Klaus | |
| 245 | 0 | 0 |
_aPitfalls in the determination of circulating matrix metalloproteinases and their inhibitors by disregarding fundamental laboratory principles. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cJun 2013 |
||
| 300 |
_ae31 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xblood |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 |
_aProcollagen _xblood |
| 650 | 0 | 4 |
_aTachycardia, Ventricular _xblood |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xblood |
| 773 | 0 |
_tAmerican heart journal _gvol. 165 _gno. 6 _gp. e31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ahj.2013.03.012 _zAvailable from publisher's website |
| 999 |
_c22781239 _d22781239 |
||